Ryan Trasolini

Executive Officer at Shuttle Pharmaceuticals.

Earliest Form D on file: May 2026

Filed May 15, 2026

Shuttle Pharmaceuticals

Radiation-sensitizing drug for glioblastoma

Biotech, Gaithersburg MD

Named, Executive Officer.

$9.955M

sold of $9.955M offered

Network

At Shuttle Pharmaceuticals

5 people

Christopher Cooper
Executive Officer, Director, signed as Co-Chief Executive Officer
Adam Chambers
Director
Angel Liriano
Director
George Scorsis
Director
Yuying Liang
Executive Officer